Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

EMA validates MAA for Xyndari for sickle cell disease

March 13, 2018

Sigilon Therapeutics' SIG-003 awarded EMA ATMP designation

March 12, 2018

FDA grants orphan drug designation to PTG-300 for beta-thalassemia

March 7, 2018

IRP1 targeting ameliorates Chuvash polycythemia in mice

March 2, 2018

European Commission approves Hemlibra

Feb. 28, 2018

Novo Nordisk submits regulatory applications for N8-GP in U.S. and E.U.

Feb. 28, 2018

FDA grants priority review to lusutrombopag NDA

Feb. 27, 2018

EMA committee recommends change to marketing authorization terms for Feraccru

Feb. 26, 2018

Overall survival improved with OMS-721 in thrombotic microangiopathy trial

Feb. 16, 2018

Oxford BioMedica enters collaboration and license agreement with Bioverativ in hemophilia

Feb. 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...